Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 8, 1996, Pages 825-832

  Vennix, Paul P C A ^a   Kuijpers, Wim ^b   Peters, Theo A ^b   Tonnaer, Edith L G M ^b   Ramaekers, Frans C S ^c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; CYTOKERATIN;

ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL INFILTRATION; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EARDRUM PERFORATION; HUMAN; HUMAN TISSUE; KERATINOCYTE;

EID: 0029778757     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890200015003     Document Type: Article

References (34)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepier R. The catalogue of Human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11-24.
2. Sun TT, Tseng SCG, Huary AJW, et al. Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann N Y Acad Sci. 1985;455:307-329.
3. Lane EB, Bartek J, Purkis PE, Leigh IM. Keratin antigens in differentiating skin. Ann N Y Acad Sci. 1985;455:241-258.
4. Ramaekers FCS, Vooijs GP, Smedts F. Keratins as differentiation markers in tumor biology and surgical pathology. In: Spandidos D, ed. Current Perspectives on Molecular and Cellular Oncology. London, England: JAI Press; 1992; 1(pt A):285-318.
5. Broekaert D, Cornille A, Eto H, et al. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Virchows Arch A Pathol Anat. 1988;413:39-51.
6. van Blitterswijk CA, Grote JJ, Lutgert RW, et al. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Ann Otol Rhinol Laryngol. 1989;98: 635-640.
7. Vennix PPCA, Kuijpers W, Tonnaer ELGM, Peters TA, Ramaekers FCS. Cytokeratins in induced epidermoid formations and cholesteatoma lesions. Arch Otolaryngol Head Neck Surg. 1990;116:560-565.
8. Lee RJ, Mackenzie IC, Hall BK, Gantz BJ. The nature of the epithelium in acquired cholesteatoma. Clin Otolaryngol. 1991;16:168-173.
9. Vennix PPCA, Kuijpers W, Peters TA, Tonnaer ELGM, Ramaekers FCS. Growth and differentiation of meatal skin grafts in the middle ear of the rat. Arch Otolaryngol Head Neck Surg. 1994;120:1102-1111.
10. Broekaert D, Coucke P, Lepergue S, et al. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol. 1992;101:931-938.
11. Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh). 1993;113:364-368.
12. Sasaki H, Huang CC. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Surg. 1994;110:310-317.
13. Lepercque S, Broekaert D, van Cauwenberge P. Cytokeratin expression patterns in the human tympanic membrane and external ear canal. Ear Arch Otorhinolaryngol. 1993;250:78-81.
14. Vennix PPCA, Kuijpers W, Peters TA, Tonnaer ELGM, Ramaekers FCS. Epidermal differentiation in the human external auditory meatus. Laryngoscope. In press.
15. Verhagen APM, Aalders TW, Ramaekers FCS, Debruyne FMJ, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate. 1988;13: 25-38.
16. Ramaekers FCS, Huysmans A, Schaart G, Moesker O, Vooijs GP. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res. 1987;170:235-249.
17. Schaafsma HE, Ramaekers FCS, van Muijen GNP, Doms ECM, Ruiter DJ. Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract. Histochemistry. 1989;91:151-159.
18. Broers JLV, Carney DN, Klein Rot M, et al. Intermediate filament proteins in classic and variant types of small lung carcinoma cell lines: a biochemical and immunological analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci. 1986;83:37-60,
19. Moll R, Dhouailly D, Sun T-T. Expression of keratin 5 as a distinctive feature of epithelia and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AE 14. Virchows Arch B Cell Pathol 1989;58:129-145.
20. Wetzels RHW, Kuijpers HJH, Lane EB, et al. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol. 1991;138:751-763.
21. Troyanovsky SM, Gueistein VI, Tchipysheva TA, Krutovshkikh VA, Bannikov GA. Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 1989;93:419-426.
22. Ramaekers FCS, Puts JJG, Moesker O, et al. Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J. 1983;15:691-713.
23. van Muijen GNP, Ruiter DJ, Franke WW, et al. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins Nos. 4 and 13. Exp Cell Res. 1986;162:97-113.
24. Osborn M, Debus E, Weber K. Monoclonal antibodies specific for vimentin. Eur J Cell Biol. 1984;34:137-146.
25. Foellmer HG, Madri JA, Furthmayr H. Monoclonal antibodies to type IV collagen: probes for the study of structure and function of basement membranes. Lab Invest. 1983;48:639-649.
26. Leigh IM, Purkis PE, Bruckner-Tuderman L. LH 7.2 monoclonal antibody dev tects type VII collagen in the sublamina densa zone of ectodermally-derived epithelia including skin. Epithelia. 1987;1:17-29.
27. Mansbridge JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol. 1987;89:253-263.
28. Weiss RA, Guillet GYA, Freedberg JM, et al. The use of a monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining patterns. J Invest Dermatol. 1983;81:224-230.
29. Thewes M, Stadler R, Korge B, Mischke D. Normal psoriatic epidermis of hyperproliferation-associated keratins. Arch Dermatol Res. 1991;283:465-471.
30. Lim DJ. Epithelial invasion, contact guidance and contact inhibition. In: Sade J, ed. Choiesteatoma and Mastoid Surgery. Amsterdam, the Netherlands: Kugler Publishers: 1982:141-152.
31. Nickoloff BJ, Naidu Y. Pertubation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol. 1994;30: 535-546.
32. Kupper TS. Immune and inflammatory processes in cutaneous tissues: mechanisms and speculations. Clin Invest. 1990;86:707-716.
33. Jiang CK, Magnaido T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M. Epidermal growth factor and transforming growth factor alfa specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc Natl Acad Sci U S A. 1993;90:6786-6790.
34. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expressions of integrins and basement membrane components by wound keratinocytes. J Clin Invest. 1993;92:1425-1435.